TSC2 and neoplasm: We observed that salinomycin as a single agent could markedly block tumour spheroid formation of Tsc2−/− MEFs in soft agar (Figure 5A) as well as TSC-patient derived AML cells that also lack Tsc2 (Figure 5B).